Acciones Reata Pharmaceuticals, Inc.
Acciones
RETA
US75615P1030
Biotecnología e investigación médica
Último transcript sobre Reata Pharmaceuticals, Inc.
Directores | Puesto | Edad | Desde |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director of Finance/CFO | 60 | 26/09/23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01/09/22 |
Director/Board Member | - | 26/09/23 | |
Michael Dambach
BRD | Director/Board Member | - | 26/09/23 |
Nombre | Peso | AuM | Varia. 1 de ene. | Calificación inversor |
---|---|---|---|---|
0.10% | 0 M€ | 0,00 % | - | |
0.07% | 0 M€ | 0,00 % | - | |
0.05% | 0 M€ | -.--% | - | |
0.04% | 0 M€ | -.--% |
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,93 % | 106 mil M | |
+7,02 % | 23,47 mil M | |
-14,60 % | 21,9 mil M | |
-7,05 % | 18,77 mil M | |
-38,55 % | 17,85 mil M | |
-8,83 % | 16,78 mil M | |
+5,51 % | 14,41 mil M | |
+37,49 % | 12,86 mil M | |
+329,39 % | 8778,45 M |